Form D Explorer

Source evidence

Cerium Pharmaceuticals, Inc. · 0001677995-26-000003

D filed Aug. 6, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
GAITHERSBURG
street1
312 MAIN STREET
street2
SUITE 300
zipCode
20878
entityName
Cerium Pharmaceuticals, Inc.
entityType
Corporation
stateOrCountry
Maryland
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold750000number750000/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount2544000number2544000/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count4number4/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 4e584aa7523b6378a52aacfad135cbedaa8809969ce8f9f46747921f98954955. This proves extraction identity, not the accuracy of the filer's claims.